• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International Journal of Virology and Molecular Biology >A Booster Dose for Hepatitis B Vaccine should be Recommended by EPI in Saudi Arabia at Adolescence and Young Adulthood
【24h】

A Booster Dose for Hepatitis B Vaccine should be Recommended by EPI in Saudi Arabia at Adolescence and Young Adulthood

机译：EPI应该在沙特阿拉伯的青春期和青年期推荐加强剂量的乙肝疫苗

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose: In 1989, hepatitis B vaccine program was started in Kingdom of Saudi Arabia (KSA). Most of the workers tested immunological status of vaccinated peoples by booster doses but did not investigate their susceptibility to hepatitis B virus (HBV) infection. Our study aimed to evaluate the immune status against HBV in Saudis vaccinated with HBV vaccine and their rate of HBV infection. Methods: Random blood samples were collected from blood donors and quantitatively screened for the antibodies directed to HBsAg (anti-HBs). Data regarding percent coverage of hepatitis B vaccination and HBV infection in different age ranges in KSA from 2002-2013 were collected. Results14 years age-old. Conclusions14 years age-old. A booster dose at that age is required to prevent adolescent and young adult HBV acquirement.
机译：目的：1989年，沙特阿拉伯王国（KSA）开始了乙肝疫苗计划。大多数工人通过加强剂量测试了疫苗接种人群的免疫状况，但没有调查他们对乙型肝炎病毒（HBV）感染的易感性。我们的研究旨在评估接种HBV疫苗的沙特阿拉伯人的HBV免疫状况及其HBV感染率。方法：从献血者中收集随机血液样本，并定量筛选针对HBsAg的抗体（抗HBs）。收集了2002-2013年KSA中不同年龄范围的乙肝疫苗接种率和HBV感染百分比的数据。结果14岁。结论14岁。在该年龄需要加强剂量以预防青少年和年轻成人HBV的获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号